Michigan HB4252 mandates that generic drug names appear on blister packaging in Michigan.
Michigan HB4252 amends the Public Health Code to require that generic drug names be displayed on blister packaging for drugs distributed in Michigan. This applies to drugs packaged or repackaged in blister packs by manufacturers, except for controlled substances. The generic name must appear on each blister cell or, if not applicable, on the backing of the blister pack. This change aims to ensure consumers have clear information about the medications they are using.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.